Profound delayed thrombocytopenia presenting 16 days after Abciximab (Reopro®) administration.
Platelets
; 22(4): 302-4, 2011.
Article
en En
| MEDLINE
| ID: mdl-21526887
ABSTRACT
Abciximab occasionally causes severe thrombocytopenia. This is variable in severity and usually occurs within hours of administration but has been reported to present up to 8 days later. This report describes a case of life-threatening thrombocytopenia 16 days following Abciximab administration. The patient required supportive transfusions and ultimately improved following dexamethasone and intravenous immunoglobulin. The case represents the longest delay between Abciximab administration and thrombocytopenia published to date.
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Trombocitopenia
/
Fragmentos Fab de Inmunoglobulinas
/
Inhibidores de Agregación Plaquetaria
/
Anticuerpos Monoclonales
Límite:
Aged
/
Humans
/
Male
Idioma:
En
Año:
2011
Tipo del documento:
Article